BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26718026)

  • 1. Anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through NF-κB/p53-apoptosis signaling pathway.
    Zhao X; Jiang K; Liang B; Huang X
    Oncol Rep; 2016 Feb; 35(2):669-75. PubMed ID: 26718026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous extract of Tribulus terrestris Linn induces cell growth arrest and apoptosis by down-regulating NF-κB signaling in liver cancer cells.
    Kim HJ; Kim JC; Min JS; Kim MJ; Kim JA; Kor MH; Yoo HS; Ahn JK
    J Ethnopharmacol; 2011 Jun; 136(1):197-203. PubMed ID: 21549825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Impact of Xanthohumol and Phenethyl Isothiocyanate and Their Combination on Nrf2 and NF-κB Pathways in HepG2 Cells In Vitro and Tumor Burden In Vivo.
    Cykowiak M; Krajka-Kuźniak V; Kleszcz R; Kucińska M; Szaefer H; Piotrowska-Kempisty H; Plewiński A; Murias M; Baer-Dubowska W
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578877
    [No Abstract]   [Full Text] [Related]  

  • 4. Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells.
    Liu B; Shi Y; Peng W; Zhang Q; Liu J; Chen N; Zhu R
    Mol Med Rep; 2016 Jul; 14(1):159-64. PubMed ID: 27176768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of MALAT1 sensitizes liver cancer cells to 5-flurouracil by regulating apoptosis through IKKα/NF-κB pathway.
    Ji DG; Guan LY; Luo X; Ma F; Yang B; Liu HY
    Biochem Biophys Res Commun; 2018 Jun; 501(1):33-40. PubMed ID: 29702091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells.
    Dorn C; Weiss TS; Heilmann J; Hellerbrand C
    Int J Oncol; 2010 Feb; 36(2):435-41. PubMed ID: 20043079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthohumol chalcone acts as a powerful inhibitor of carcinogenesis in drug-resistant human colon carcinoma and these effects are mediated via G2/M phase cell cycle arrest, activation of apoptotic pathways, caspase activation and targeting Ras /MEK/ERK pathway.
    Liu X; An LJ; Li Y; Wang Y; Zhao L; Lv X; Guo J; Song AL
    J BUON; 2019; 24(6):2442-2447. PubMed ID: 31983118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
    Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
    Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma.
    Kunnimalaiyaan S; Sokolowski KM; Balamurugan M; Gamblin TC; Kunnimalaiyaan M
    PLoS One; 2015; 10(5):e0127464. PubMed ID: 26011160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginkgo biloba Extract Mechanism Inhibits Hepatocellular Carcinoma through the Nuclear Factor-κB/p53 Signaling Pathway.
    Wang R; Shao X; Yang J; Liu Z; Chew L; Shao Y
    J Environ Pathol Toxicol Oncol; 2020; 39(2):179-189. PubMed ID: 32749126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K/Akt/NF-κB signaling pathway.
    Chen H; Huang Y; Huang J; Lin L; Wei G
    Oncol Rep; 2017 Feb; 37(2):865-870. PubMed ID: 27959444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanthohumol decreases Notch1 expression and cell growth by cell cycle arrest and induction of apoptosis in epithelial ovarian cancer cell lines.
    Drenzek JG; Seiler NL; Jaskula-Sztul R; Rausch MM; Rose SL
    Gynecol Oncol; 2011 Aug; 122(2):396-401. PubMed ID: 21616523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
    Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
    Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
    Kang Y; Park MA; Heo SW; Park SY; Kang KW; Park PH; Kim JA
    Biochim Biophys Acta; 2013 Mar; 1830(3):2638-48. PubMed ID: 23246576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of sappanchalcone-induced growth inhibition and apoptosis in human oral cancer cells.
    Lee YM; Kim YC; Choi BJ; Lee DW; Yoon JH; Kim EC
    Toxicol In Vitro; 2011 Dec; 25(8):1782-8. PubMed ID: 21963806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthohumol induces phase II enzymes via Nrf2 in human hepatocytes in vitro.
    Krajka-Kuźniak V; Paluszczak J; Baer-Dubowska W
    Toxicol In Vitro; 2013 Feb; 27(1):149-56. PubMed ID: 23085367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
    Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthohumol, a prenylated flavonoid from Hops, exerts anticancer effects against gastric cancer in vitro.
    Wei S; Sun T; Du J; Zhang B; Xiang D; Li W
    Oncol Rep; 2018 Dec; 40(6):3213-3222. PubMed ID: 30272303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JIB‑04 induces cell apoptosis via activation of the p53/Bcl‑2/caspase pathway in MHCC97H and HepG2 cells.
    Liao W; Liu J; Liu B; Huang X; Yin Y; Cai D; Li M; Zhu R
    Oncol Rep; 2018 Dec; 40(6):3812-3820. PubMed ID: 30272369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xanthohumol inhibits cellular proliferation in a breast cancer cell line (MDA-MB231) through an intrinsic mitochondrial-dependent pathway.
    Yoo YB; Park KS; Kim JB; Kang HJ; Yang JH; Lee EK; Kim HY
    Indian J Cancer; 2014; 51(4):518-23. PubMed ID: 26842182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.